HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Immunoscintigraphy of bone marrow in plasmacytoma].

Abstract
In 26 patients with plasmocytoma and 4 patients with benign monoclonal gammopathy bone marrow scintigraphy using 99mTc-labelled monoclonal antigranulocyte-antibodies was performed. Focal marrow defects were found in 18/26 patients with plasmocytoma but in none with benign monoclonal gammopathy. The results in plasmocytoma patients correlated well with the clinical staging system of Durie and Salmon. Quantification showed a suppressed bone marrow uptake ratio in 8/26 patients. A marked bone marrow expansion was present in only 2/26 patients. Bone marrow scintigraphy seems to be a valuable diagnostic tool in patients with plasmocytoma, especially as it is able to visualize the degree of bone marrow infiltration in a single protocol and so allows to follow up patients in a simple noninvasive manner.
AuthorsJ Bathmann, W Brugger, C Ullrich, R Mertelsmann, E Moser
JournalNuklearmedizin. Nuclear medicine (Nuklearmedizin) Vol. 34 Issue 2 Pg. 66-70 (Apr 1995) ISSN: 0029-5566 [Print] Germany
Vernacular TitleImmunszintigraphie des Knochenmarks beim Plasmozytom.
PMID7761276 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Technetium
Topics
  • Antibodies, Monoclonal
  • Bone Marrow (diagnostic imaging)
  • Diagnosis, Differential
  • Humans
  • Neoplasm Staging
  • Paraproteinemias (diagnostic imaging)
  • Plasmacytoma (diagnostic imaging, pathology)
  • Radioimmunodetection (methods)
  • Technetium

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: